Widad inks agreement with Rinani


KUALA LUMPUR: Widad Group Bhd has signed a memorandum of collaboration with Rinani Dynamic Sdn Bhd for the distribution, marketing and selling of the Covid-19 vaccine.

In a statement Tuesday, Widad said Rinani is the local representative in Malaysia for VAXART Inc, an US-based entity that is listed on Nasdaq with respect to its ongoing development of an oral-based (tablet) Covid-19 vaccine.

Celebrate Merdeka with 50% Off!
T&C applies.

Monthly Plan

RM13.90/month
RM6.95 only

Billed as RM6.95 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM6.17/month

Billed as RM78 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Widad , Rinani , Vaxart , Covid-19

   

Next In Business News

Oil posts big weekly drop after US jobs data
A class above
Investors with Australian property: Beware TAX
Getting a good price for your home
Investing amid shifting expectations
Economic proxy play
Putting money on the banks
Higher credit score, better mortgage options
Is TM better off exiting DNB?
Gamuda wins Sabah power project

Others Also Read